Natus Medical Inc news

   Watch this stock
Showing stories 1 - 10 of about 80   

Articles published

BABY 32.70 +0.77 (2.41%)
price chart
Why Natus Medical Inc. Reported Lower Today
What: Natus Medical (NASDAQ:BABY) is down 18% at 12:30 p.m. ET after releasing preliminary first-quarter revenue numbers that were lower than previous guidance.
Earnings Watch: Natus Medical Inc (NASDAQ:BABY)  The Point Review
Natus Medical (BABY) Stock Plunges on Preliminary Q1 Revenue  TheStreet.com
3 Things to Watch as Natus Medical Inc Reports Earnings
Like the previous quarter, Natus Medical's (NASDAQ:BABY) top-line results for the first quarter are going to be unsurprising when the company reports earnings on Wednesday since the revenue number was already disclosed. In both quarters, the story was ...
Natus Medical Inc Says Adios to Venezuela Guidance
Natus Medical (NASDAQ:BABY) reported revenue of $87.3 million in the first quarter, just shy of the preliminary number of "approximately $87.5 million" that was disclosed earlier this month when the company said it wasn't going to hit its guidance ...
Hagens Berman Investigates Natus Medical Inc.'s Guidance on Prepayments ...  Business Wire (press release)
1 Thing to Watch As Natus Medical Inc. Reports Earnings
Editor's note: An earlier version of this article incorrectly reported that Natus had announced preliminary guidance for Q4 2015.
Natus Medical Inc. Serving Up Earning Growth
When Natus Medical (NASDAQ:BABY) released earnings on Wednesday, there wasn't much of a surprise on the revenue side, since the company had already released a preliminary tally of "approximately $100.0 million" in revenue for the fourth quarter.
Natus Medical shares jump on Q4, FY2015 EPS beat  Mass Device
Natus Medical downgraded to market perform from outperform at Raymond James
Natus Medical Inc. NASDAQ: BABY. GO. Set Alerts · Find a Broker · Join TD Ameritrade · Market Index · Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.
Natus Medical Inc. Serves Up a New Business Model
Natus Medical (NASDAQ:BABY) continues to fire on all cylinders. It's hard to find something to complain about the medical device maker specializing in neurology and care for newborns.
Natus Medical (BABY) Beats Q4 Earnings, Revenues in Line  Zacks.com
Natus Medical Has The Right Growth Metrics BABY (BABY)  Seeking Alpha (registration)
Adding Up Baby Steps at Natus Medical Inc.
Without any large acquisitions to help artificially boost sales as we've seen in the past, Natus Medical (NASDAQ:BABY), a purveyor of medical devices specializing in neurology and care for newborns, keeps chugging along.
Natus Medical Inc. Hears Higher Margins Calling
Organic revenue growth of 5% is nothing to get too excited about, but increasing margins made for a nice bottom-line improvement at Natus Medical (NASDAQ:BABY). Non-GAAP net income increased 16.5% year over year in the third quarter to $10.6 million.
Related articles »  
News Natus Medical Inc.BABY
News Natus Medical Inc.BABY. Significant News Only. 05/09/16; Press Release. Lifshitz & Miller Law Firm Announces Investigation of Amaya, Inc., Chiasma, Inc., Intrexon Corporation, Natus Medical Inc., NRG Yield, Inc., Sunrun Inc., TransEnterix and ...